Stay up-to-date and never miss a thing.

Exciting news from PELOBiotech and Partners.


Alternatives to Matrigel

From BPr 19. Juli 2022 2

No Matrigel at hand? Our new partner Tissue Click offers PhenoDrive which has a multifunctional nature.


New Cell Culture Supplement - gamma irradiated viral inactivated

From BPr 18. Juli 2022 2

Want to go PURE? EV-free research and production are getting more and more impact through all main application fields.


Improving your 3D Cell culture with spider silk fiber

From BPr 18. Juli 2022 4

HydroSeev, by our partner Seevix, is a formulation of a biopolymer with properties like that of spider silk used as an additive for the betterment of mechanical properties, viability and function of 3D models. It is supplied as a stock suspension to supplement materials used for creating 3D Cellular models.


ECM molecules are important targets for pharmacotherapy.

From BPr 18. Juli 2022 5

Extracellular Matrix (ECM) is the non cellular component present within all tissues and organs, and provides essential physical scaffolding for the cellular constituents and also initiates crucial biochemical and biomechanical cues required for tissue mor-phogenesis, differentiation and homeostasis.


Which impact an extracellular matrix (ECM) has on your research

From BPr 04. Juli 2022 5

Why Extracellular matrix (ECM) based research on highlight.


Make your proteomic research easier!

From BPr 13. Juni 2022 5

MagReSyn® Ultra-Capacity high performance magnetic microparticles are used for Mass Spectrometry sample preparation in proteomics. The product is developed to improve the reproducibility and automation of Mass Spectrometry and Bioseperation workflows. And to provide high capacity and specificity.


Solve the Mystery: How the complex Network of Proteins and Polysaccharides Influence your set-up

From BPr 03. Juni 2022 5

Extracellular Vesicles (EV) are the entities that are secreted by different cells and their function is to help in cell-cell communication. They take ...


PELOAcademy | Glaucoma - One Step Ahead with In-vitro Models

From CB 14. Februar 2022

Please register for

PELOAcademy | Glaucoma - One Step Ahead with In-vitro Models

Thu, March 31 , 2022 10:00 AM CET

presented by Tommaso Sbrana, CEO IVtech, Italy

Glaucoma is a neurodegenerative disease characterized by optic nerve damage and the slow progressive death of retinal ganglion cells (RGCs).

Please share this info with your friends & co-workers. Thank you.

#microfluidics #3Dcellculture #In-VitroModels #multipleorgantesting #glaucomaresearch #gruenerstar